Answers are grounded in this paper and cite their sources.
The addition of temozolomide to radiotherapy for newly diagnosed glioblastoma resulted in a clinically meaningful and statistically significant survival benefit with minimal additional toxicity.
No takes yet. Share an insight, caveat, or question.
Stupp et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: